Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
Economic analysis of combination levothyroxine plus liothyronine therapy based on the 1999 Bunevicius trial: cost per QALY modeling, payer coverage barriers, list-price realities, and individual value calculations.
Read clinical reviewWhat happened after the landmark 1999 Bunevicius trial ended? This deep dive covers follow-up data, durability of T4+T3 combination benefits, regression-to-mean concerns, and long-term safety signals.
Read clinical reviewA deep-dive into pre-specified and post-hoc subgroup analyses from the 1999 Bunevicius NEJM trial, examining which patient groups responded best to T4+T3 combination therapy versus levothyroxine alone, and what that means for clinical decision-making today.
Read clinical reviewA deep-dive into the 1999 Bunevicius NEJM trial comparing levothyroxine plus liothyronine (T4+T3) to levothyroxine alone for hypothyroidism, covering methodology, results, limitations, and clinical relevance today.
Read clinical reviewA deep-dive into the 1999 Bunevicius crossover trial of levothyroxine plus liothyronine combination therapy, examining its real clinical implications, guideline responses, and which patients may benefit today.
Read clinical review